# Environment Strategy

**Version:** 0.1  
**Status:** Draft

## 1. Environments

### Local Development
Synthetic data only.

### CI/Test
Automated tests and ephemeral test databases.

### Staging / Pre-production
Production-like configuration with synthetic data.

### Production
Live pilot data and strictly controlled access.

## 2. Separation

Each environment should have separate:

- database;
- object storage;
- secrets;
- credentials;
- external-provider configuration.

## 3. Production Data

Production patient/clinical data must not be copied into development or routine staging.

## 4. Access

Production access:

- least privilege;
- individual accounts;
- MFA;
- audited;
- time-limited where possible.

## 5. Configuration

Environment-specific settings must not require source-code modification.

## 6. Test Providers

Use sandbox/test accounts for:

- email/SMS;
- storage;
- identity;
- monitoring

where available.

## 7. Promotion

Deploy the same tested build artifact through environments where practical.

## 8. Emergency Changes

Emergency production changes require retrospective review and documentation.

---

### Documentation Attribution

**Documentation framework, repository structure, methodology expression, and original authored contributions:** **Alfatih Abdalla**  
[Email](mailto:Fabdalla782@gmail.com) · [LinkedIn](https://www.linkedin.com/in/alfatihabdalla) · [GitHub](https://github.com/fatihg80)

© 2026 Alfatih Abdalla. This attribution applies to Alfatih Abdalla’s original documentation contributions and organizational expression in this repository. Source materials and third-party contributions retain their respective authorship and rights.
